nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCD—liver—gallbladder cancer	0.00826	0.218	CbGeAlD
Ingenol Mebutate—PRKCA—epithelium—gallbladder cancer	0.00803	0.212	CbGeAlD
Ingenol Mebutate—PRKCA—pancreas—gallbladder cancer	0.00715	0.189	CbGeAlD
Ingenol Mebutate—PRKCD—lymph node—gallbladder cancer	0.00633	0.167	CbGeAlD
Ingenol Mebutate—PRKCA—liver—gallbladder cancer	0.00455	0.12	CbGeAlD
Ingenol Mebutate—PRKCA—lymph node—gallbladder cancer	0.00349	0.0923	CbGeAlD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	0.00184	0.00191	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—EGFR—gallbladder cancer	0.00183	0.00191	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	0.00183	0.0019	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—TP53—gallbladder cancer	0.00183	0.0019	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—EGFR—gallbladder cancer	0.00182	0.0019	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—EGFR—gallbladder cancer	0.00182	0.0019	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—NRAS—gallbladder cancer	0.00182	0.0019	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—EGFR—gallbladder cancer	0.00182	0.00189	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—EGFR—gallbladder cancer	0.00181	0.00188	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—EGFR—gallbladder cancer	0.00181	0.00188	CbGpPWpGaD
Ingenol Mebutate—PRKCD—PDGFR-beta signaling pathway—HRAS—gallbladder cancer	0.0018	0.00187	CbGpPWpGaD
Ingenol Mebutate—PRKCA—G Protein Signaling Pathways—NRAS—gallbladder cancer	0.00179	0.00186	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Endothelins—HRAS—gallbladder cancer	0.00179	0.00186	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—EGFR—gallbladder cancer	0.00177	0.00184	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—ERBB4—gallbladder cancer	0.00177	0.00184	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—ERBB4—gallbladder cancer	0.00176	0.00183	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—HRAS—gallbladder cancer	0.00175	0.00182	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—KRAS—gallbladder cancer	0.00173	0.0018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling in naïve CD8+ T cells—HRAS—gallbladder cancer	0.00173	0.00179	CbGpPWpGaD
Ingenol Mebutate—PRKCA—TCR signaling in naïve CD4+ T cells—HRAS—gallbladder cancer	0.00173	0.00179	CbGpPWpGaD
Ingenol Mebutate—PRKCA—mTOR signaling pathway—HRAS—gallbladder cancer	0.00173	0.00179	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—KRAS—gallbladder cancer	0.00172	0.00179	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.00172	0.00179	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—KRAS—gallbladder cancer	0.00171	0.00178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—KRAS—gallbladder cancer	0.00171	0.00177	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—KRAS—gallbladder cancer	0.00171	0.00177	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—EGFR—gallbladder cancer	0.0017	0.00177	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—EGFR—gallbladder cancer	0.0017	0.00177	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—ERBB2—gallbladder cancer	0.00169	0.00176	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—EGFR—gallbladder cancer	0.00168	0.00175	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—KRAS—gallbladder cancer	0.00167	0.00174	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—ERBB2—gallbladder cancer	0.00167	0.00174	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—EGFR—gallbladder cancer	0.00167	0.00173	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—EGFR—gallbladder cancer	0.00166	0.00173	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	0.00165	0.00172	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—NRAS—gallbladder cancer	0.00163	0.00169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—ERBB2—gallbladder cancer	0.00162	0.00168	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—HRAS—gallbladder cancer	0.00161	0.00167	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—KRAS—gallbladder cancer	0.00161	0.00167	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.00161	0.00167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—NRAS—gallbladder cancer	0.0016	0.00167	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	0.0016	0.00166	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—KRAS—gallbladder cancer	0.00159	0.00165	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—TP53—gallbladder cancer	0.00159	0.00165	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	0.00158	0.00164	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—KRAS—gallbladder cancer	0.00157	0.00163	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	0.00157	0.00163	CbGpPWpGaD
Ingenol Mebutate—PRKCA—G Protein Signaling Pathways—KRAS—gallbladder cancer	0.00154	0.0016	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—ERBB3—gallbladder cancer	0.00153	0.00159	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—ERBB3—gallbladder cancer	0.00152	0.00158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—ERBB2—gallbladder cancer	0.00152	0.00158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—TP53—gallbladder cancer	0.00152	0.00158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—NRAS—gallbladder cancer	0.00151	0.00157	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—ERBB2—gallbladder cancer	0.00151	0.00157	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—ERBB2—gallbladder cancer	0.00151	0.00157	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.00151	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—ERBB2—gallbladder cancer	0.0015	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—ERBB2—gallbladder cancer	0.0015	0.00156	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TP53—gallbladder cancer	0.00149	0.00155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—EGFR—gallbladder cancer	0.00148	0.00154	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Insulin Signaling—HRAS—gallbladder cancer	0.00148	0.00154	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—HRAS—gallbladder cancer	0.00147	0.00153	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.00146	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—HRAS—gallbladder cancer	0.00146	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—HRAS—gallbladder cancer	0.00146	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.00145	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—HRAS—gallbladder cancer	0.00145	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—HRAS—gallbladder cancer	0.00145	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.00142	0.00148	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—NRAS—gallbladder cancer	0.00142	0.00147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—ERBB2—gallbladder cancer	0.00141	0.00146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—ERBB2—gallbladder cancer	0.00141	0.00146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—KRAS—gallbladder cancer	0.0014	0.00146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—ERBB2—gallbladder cancer	0.0014	0.00145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—ERBB2—gallbladder cancer	0.00138	0.00144	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—KRAS—gallbladder cancer	0.00138	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—ERBB2—gallbladder cancer	0.00138	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.00137	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.00136	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—HRAS—gallbladder cancer	0.00136	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.00136	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—HRAS—gallbladder cancer	0.00135	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—EGFR—gallbladder cancer	0.00135	0.0014	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.00134	0.00139	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—HRAS—gallbladder cancer	0.00133	0.00139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.00132	0.00138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—G Protein Signaling Pathways—HRAS—gallbladder cancer	0.00131	0.00136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—KRAS—gallbladder cancer	0.0013	0.00135	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—NRAS—gallbladder cancer	0.00129	0.00134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—NRAS—gallbladder cancer	0.00129	0.00134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—gallbladder cancer	0.00127	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—NRAS—gallbladder cancer	0.00127	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—ERBB2—gallbladder cancer	0.00125	0.0013	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KEAP1—gallbladder cancer	0.00124	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—NRAS—gallbladder cancer	0.00123	0.00128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—KRAS—gallbladder cancer	0.00122	0.00127	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.00121	0.00126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—HRAS—gallbladder cancer	0.00119	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—HRAS—gallbladder cancer	0.00117	0.00122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—EGFR—gallbladder cancer	0.00117	0.00122	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.00117	0.00121	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—EGFR—gallbladder cancer	0.00116	0.0012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—NRAS—gallbladder cancer	0.00116	0.0012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—NRAS—gallbladder cancer	0.00115	0.0012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—NRAS—gallbladder cancer	0.00114	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—NRAS—gallbladder cancer	0.00114	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—gallbladder cancer	0.00113	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—EGFR—gallbladder cancer	0.00112	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—KRAS—gallbladder cancer	0.00111	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—HRAS—gallbladder cancer	0.00111	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—KRAS—gallbladder cancer	0.00111	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—KRAS—gallbladder cancer	0.00109	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—NRAS—gallbladder cancer	0.00107	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—NRAS—gallbladder cancer	0.00107	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—NRAS—gallbladder cancer	0.00106	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—KRAS—gallbladder cancer	0.00106	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—EGFR—gallbladder cancer	0.00105	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—NRAS—gallbladder cancer	0.00105	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—EGFR—gallbladder cancer	0.00105	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—EGFR—gallbladder cancer	0.00105	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—NRAS—gallbladder cancer	0.00105	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—EGFR—gallbladder cancer	0.00104	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—EGFR—gallbladder cancer	0.00104	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—HRAS—gallbladder cancer	0.00104	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ERBB4—gallbladder cancer	0.00102	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ERBB4—gallbladder cancer	0.00101	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—KRAS—gallbladder cancer	0.000995	0.00103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—KRAS—gallbladder cancer	0.00099	0.00103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.00099	0.00103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—KRAS—gallbladder cancer	0.000985	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—BCL2—gallbladder cancer	0.000981	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—KRAS—gallbladder cancer	0.00098	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—EGFR—gallbladder cancer	0.000976	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—EGFR—gallbladder cancer	0.000976	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—EGFR—gallbladder cancer	0.000967	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—ERBB2—gallbladder cancer	0.000959	0.000997	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—EGFR—gallbladder cancer	0.000959	0.000996	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—EGFR—gallbladder cancer	0.000955	0.000992	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—ERBB2—gallbladder cancer	0.000953	0.00099	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—NRAS—gallbladder cancer	0.000949	0.000986	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—gallbladder cancer	0.000946	0.000983	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—HRAS—gallbladder cancer	0.000946	0.000983	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ERBB4—gallbladder cancer	0.000945	0.000982	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—HRAS—gallbladder cancer	0.00094	0.000977	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—HRAS—gallbladder cancer	0.00093	0.000966	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—KRAS—gallbladder cancer	0.000922	0.000958	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—KRAS—gallbladder cancer	0.000922	0.000958	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.000918	0.000954	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—gallbladder cancer	0.000917	0.000953	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—KRAS—gallbladder cancer	0.000914	0.00095	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—KRAS—gallbladder cancer	0.000906	0.000941	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—KRAS—gallbladder cancer	0.000902	0.000937	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—HRAS—gallbladder cancer	0.0009	0.000935	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ERBB3—gallbladder cancer	0.000885	0.00092	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ERBB3—gallbladder cancer	0.000873	0.000907	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.000868	0.000902	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—EGFR—gallbladder cancer	0.000865	0.000898	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—HRAS—gallbladder cancer	0.00085	0.000883	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—HRAS—gallbladder cancer	0.000845	0.000879	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—HRAS—gallbladder cancer	0.000841	0.000874	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.000841	0.000874	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—HRAS—gallbladder cancer	0.000837	0.00087	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—gallbladder cancer	0.000835	0.000868	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—HRAS—gallbladder cancer	0.000833	0.000866	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ERBB3—gallbladder cancer	0.000817	0.000849	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—KRAS—gallbladder cancer	0.000817	0.000849	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—NRAS—gallbladder cancer	0.000805	0.000837	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—gallbladder cancer	0.000789	0.00082	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—HRAS—gallbladder cancer	0.000784	0.000815	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—HRAS—gallbladder cancer	0.000784	0.000815	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—HRAS—gallbladder cancer	0.000777	0.000807	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.000771	0.000801	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—HRAS—gallbladder cancer	0.00077	0.0008	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—HRAS—gallbladder cancer	0.000766	0.000797	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—NRAS—gallbladder cancer	0.00073	0.000758	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—NRAS—gallbladder cancer	0.000725	0.000753	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.000711	0.000739	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—HRAS—gallbladder cancer	0.000694	0.000721	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—KRAS—gallbladder cancer	0.000693	0.00072	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—gallbladder cancer	0.000671	0.000697	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—EGFR—gallbladder cancer	0.000665	0.000691	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ERBB4—gallbladder cancer	0.000662	0.000688	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EGFR—gallbladder cancer	0.00066	0.000686	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—KRAS—gallbladder cancer	0.000628	0.000653	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—KRAS—gallbladder cancer	0.000624	0.000648	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—gallbladder cancer	0.000616	0.00064	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—HRAS—gallbladder cancer	0.000589	0.000612	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ERBB4—gallbladder cancer	0.000588	0.000611	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ERBB3—gallbladder cancer	0.000572	0.000595	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—BCL2—gallbladder cancer	0.000571	0.000594	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—BCL2—gallbladder cancer	0.000563	0.000585	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ERBB2—gallbladder cancer	0.000555	0.000577	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ERBB2—gallbladder cancer	0.000547	0.000569	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—HRAS—gallbladder cancer	0.000545	0.000566	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ERBB4—gallbladder cancer	0.000543	0.000564	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—HRAS—gallbladder cancer	0.000534	0.000555	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—HRAS—gallbladder cancer	0.00053	0.000551	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ERBB2—gallbladder cancer	0.000512	0.000532	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ERBB3—gallbladder cancer	0.000508	0.000528	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ERBB3—gallbladder cancer	0.000469	0.000488	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NRAS—gallbladder cancer	0.000462	0.000481	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—NRAS—gallbladder cancer	0.000462	0.00048	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NRAS—gallbladder cancer	0.000422	0.000439	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—gallbladder cancer	0.000421	0.000437	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NRAS—gallbladder cancer	0.000416	0.000433	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—KRAS—gallbladder cancer	0.000398	0.000414	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—KRAS—gallbladder cancer	0.000398	0.000413	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NRAS—gallbladder cancer	0.00039	0.000405	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—gallbladder cancer	0.000385	0.0004	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ERBB4—gallbladder cancer	0.00038	0.000395	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—gallbladder cancer	0.000379	0.000394	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—KRAS—gallbladder cancer	0.000363	0.000378	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ERBB2—gallbladder cancer	0.000359	0.000373	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—KRAS—gallbladder cancer	0.000358	0.000372	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—gallbladder cancer	0.000355	0.000369	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—gallbladder cancer	0.000354	0.000368	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—HRAS—gallbladder cancer	0.000338	0.000352	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—HRAS—gallbladder cancer	0.000338	0.000351	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—KRAS—gallbladder cancer	0.000335	0.000349	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—gallbladder cancer	0.000334	0.000347	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ERBB3—gallbladder cancer	0.000329	0.000342	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—BCL2—gallbladder cancer	0.000328	0.000341	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ERBB2—gallbladder cancer	0.000319	0.000331	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HRAS—gallbladder cancer	0.000309	0.000321	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HRAS—gallbladder cancer	0.000305	0.000316	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ERBB2—gallbladder cancer	0.000294	0.000306	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HRAS—gallbladder cancer	0.000285	0.000296	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NRAS—gallbladder cancer	0.000273	0.000284	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—NRAS—gallbladder cancer	0.000265	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—gallbladder cancer	0.000249	0.000258	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NRAS—gallbladder cancer	0.000242	0.000252	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—gallbladder cancer	0.000242	0.000251	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KRAS—gallbladder cancer	0.000235	0.000244	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—KRAS—gallbladder cancer	0.000228	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NRAS—gallbladder cancer	0.000224	0.000233	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—gallbladder cancer	0.000221	0.00023	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—gallbladder cancer	0.000209	0.000217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KRAS—gallbladder cancer	0.000209	0.000217	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ERBB2—gallbladder cancer	0.000206	0.000214	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—gallbladder cancer	0.000204	0.000212	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HRAS—gallbladder cancer	0.0002	0.000208	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—HRAS—gallbladder cancer	0.000194	0.000202	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—KRAS—gallbladder cancer	0.000193	0.0002	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HRAS—gallbladder cancer	0.000177	0.000184	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HRAS—gallbladder cancer	0.000164	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NRAS—gallbladder cancer	0.000157	0.000163	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—gallbladder cancer	0.000143	0.000148	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KRAS—gallbladder cancer	0.000135	0.00014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—gallbladder cancer	0.00012	0.000125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HRAS—gallbladder cancer	0.000115	0.000119	CbGpPWpGaD
